Thus, while in NDs blocking inflammation and HDAC6-dependent inflammasome activation may be exploited as a strategy to prevent, treat, and/or ameliorate NDs symptoms [326], in cancer, the inhibition of this specific HDAC6 function is a double-edged sword. Here, HDAC6 is linked to cancer.